Improving asthma management for children in non-English speaking families
Official title: Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Languages Other Than English (Nav-TEAM)
Run by University of Colorado, Denver · NCT06239844 · Data updated 2026-11-12
This study tests a new program that helps non-English speaking families manage their children's asthma better and see if it reduces emergency room visits.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 4 Years to 89 Years |
| Sex | All |
| Enrollment | 570 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Status | Recruiting |
| Started | March 21, 2025 |
| Main results expected | October 2027 |
| Study ends | October 2028 |
| Registry record updated | April 3, 2025 |
| Trial ID | NCT06239844 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children aged 4-12 years with persistent asthma and their non-English speaking parents or guardians.
✕Probably not a fit
Patients who are English speakers or do not have persistent asthma will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of an asthma navigator program designed to assist children with asthma and their caregivers who communicate in languages other than English. The program aims to provide tailored education and support through partnerships with community organizations, addressing disparities in asthma care. The study will assess the program's impact on emergency department visits and overall asthma management practices among participating families. Additionally, it will analyze the program's costs and adherence to its goals.
Why it matters
Potential benefit: If successful, this program could significantly improve asthma management and health outcomes for children in non-English speaking families.
How similar studies have gone: While similar approaches have shown success in improving asthma outcomes for minority children, this specific focus on non-English speaking families is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
eria for Nav-TEAM Intervention Dyads include: * Child aged 4-12 years. * Child with persistent asthma (defined by currently prescribed controller medication). * Parent/legal guardian who is at least 18 years old. Exclusion criteria for Nav-TEAM Intervention Dyads include: * Child aged under 4 and over 12 years of age. * Child with no persistent asthma (defined by currently prescribed controller medication). * Parent/legal guardian who is under 18 years old. * Any parent/legal guardian whose preferred spoken language is English. * Child requires additional continuous respiratory support (e.g,. tracheostomy with home ventilation, continuous daytime oxygen). * Child is enrolled in another study health system associated asthma navigation program (e.g. school or home-visiting programs). * Spoken non-English preferred healthcare language of parent/legal guardian. * Child does NOT require additional continuous respiratory support (e.g., nighttime use of Continuous positive airway pressure machine for obstructive sleep apnea would be eligible). * Child does NOT have a complex medical/genetic condition that affects swallowing or lung function (e.g. g-tube with aspiration, cystic fibrosis) * Child is NOT enrolled in another study health system associated asthma navigation program (e.g. school or home-visiting programs).
Where it's running
-
Children's Hospital Colorado
Aurora, Colorado, United States Recruiting
Study contacts
- Study coordinator: Lisa Ross DeCamp, MD, MPH
- Email: lisa.decamp@cuanschutz.edu
- Phone: 3037246499
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
N-WATCH: Can a simple breath device help monitor asthma in kids
This study tests the N-Tidal C device to see if it helps monitor asthma in children aged 5 to under 16 who have wheeze or asthma and are not critically ill.
-
Smart Inhaler Use at Home for Adolescents with IDD and Asthma
This study tests whether daily use of active smart inhalers at home helps adolescents with intellectual disabilities manage asthma better.
-
ASMact: Managing bronchial asthma attacks in children
This study tries a GINA 2025-based staff education and care-standardization approach to see if emergency treatment for children aged 6–17 with acute asthma attacks improves outcomes.
-
Biomarkers and Respiratory Omics in Children: Predicting Disease Course
This study tests whether biomarkers from the lungs and blood can predict how asthma and protracted bacterial bronchitis in children will progress and respond to current therapies.
-
Using technology and school–clinic coordination to improve asthma care for children.
This project will try a tech-enabled program plus school care coordination to help children ages 4–12 with persistent or uncontrolled asthma follow guideline-based treatment and have fewer symptoms and school problems.
-
Boosting use of SMART inhaler therapy for children with moderate-to-severe asthma
This project will test whether adding community health workers and nurse care managers to electronic health record decision support and education helps children ages 5–18 with uncontrolled asthma use single maintenance and reliever therapy (SMART).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.